new insights from sabcs 2016 on adjuvant therapy for hr breast cancer
Published 7 years ago • 75 plays • Length 6:11Download video MP4
Download video MP3
Similar videos
-
6:04
new insights from sabcs 2016 on adjuvant therapy for hr breast cancer
-
9:31
new options for hr breast cancer - an update from sabcs 2016
-
5:12
new options for hr breast cancer - an update from sabcs 2016
-
3:36
precision medicine in breast cancer two new options from sabcs 2016
-
9:38
new combination options for hr patients: an update from sabcs 2016
-
8:33
new data on managing her2 disease from sabcs 2016
-
7:05
new data on cdk 4/6 inhibitors: an update from sabcs 2016
-
7:19
circulating dna markers for breast cancer a review of new data from sabcs 2016
-
2:11
exciting trials at sabcs 2021 for pre- vs. post-menopausal hormone receptor-positive breast cancer
-
30:56
adjuvant treatment for early stage hormone positive breast cancer: role of genomic signatures
-
3:29
t-dm1 vs. trastuzumab as adjuvant therapy for her2-positive breast cancer
-
1:22
dr. william gradishar discusses 10 years of adjuvant tamoxifen
-
0:32
highlights in her2-low breast cancer at sabcs 2022
-
7:42
axillary nodes after neoadjuvant treatment: an update from sabcs 2016
-
3:58
post-adjuvant therapy for her2 breast cancer
-
5:08
adjuvant therapy for breast cancer
-
4:04
adjuvant therapy for high-risk her2 breast cancer
-
1:24
dr. rugo on extended adjuvant hormone therapy for breast cancer
-
9:01
liquid biopsies' and endocrine therapy: an update from sabcs 2016